In light of this perspective, it would be interesting to confirm whether CD4+ T helper cells from the same cohort of ME/CFS patients can be activated by the same EBV peptides associated with the identified 26-antibody signature. This evidence concerns the gene CD4 and myalgic encephalomeyelitis/chronic fatigue syndrome.